Literature DB >> 4040199

Oxytocin reduces intravenous heroin self-administration in heroin-tolerant rats.

G L Kovács, Z Borthaiser, G Telegdy.   

Abstract

Intravenous self-administration of heroin was studied in experimentally naive rats, as compared to this behavior in animals rendered tolerant to heroin by multiple injections. The tolerant rats also exhibited mild signs of spontaneous and naloxone-precipitated heroin withdrawal. Self-administration behavior developed earlier in the tolerant rats. In heroin-naive rats, oxytocin treatment did not influence the acquisition of heroin self-administration behavior. In the tolerant rats, on the other hand, oxytocin decreased the acquisition of heroin self-administration. When maintenance of heroin self-administration was studied in the tolerant rats, graded doses of oxytocin (0.05, 0.5 and 5 micrograms s.c.) decreased heroin intake. This finding, which is in agreement with previous data indicating that oxytocin attenuates the development of tolerance to and dependence on narcotic analgesics, suggests that the neuropeptide reduced the reinforcing efficacy of heroin in the tolerant organism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040199     DOI: 10.1016/0024-3205(85)90620-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  23 in total

Review 1.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

2.  Intracranial self-stimulation of the paraventricular nucleus of the hypothalamus: increased faciliation by morphine compared to cocaine.

Authors:  Eric E Ewan; Thomas J Martin
Journal:  Anesthesiology       Date:  2012-05       Impact factor: 7.892

3.  Peripheral oxytocin administration reduces ethanol consumption in rats.

Authors:  Kaley MacFadyen; Rebecca Loveless; Brandon DeLucca; Krystal Wardley; Sumeet Deogan; Cameron Thomas; Joanna Peris
Journal:  Pharmacol Biochem Behav       Date:  2015-10-28       Impact factor: 3.533

Review 4.  Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.

Authors:  Mary R Lee; Matthew C H Rohn; Gianluigi Tanda; Lorenzo Leggio
Journal:  CNS Drugs       Date:  2016-02       Impact factor: 5.749

Review 5.  Oxytocin for the treatment of drug and alcohol use disorders.

Authors:  Mary R Lee; Elise M Weerts
Journal:  Behav Pharmacol       Date:  2016-12       Impact factor: 2.293

6.  Chronic oxytocin administration as a tool for investigation and treatment: A cross-disciplinary systematic review.

Authors:  Marilyn Horta; Kathryn Kaylor; David Feifel; Natalie C Ebner
Journal:  Neurosci Biobehav Rev       Date:  2019-10-21       Impact factor: 8.989

7.  Oxycodone self-administration during pregnancy disrupts the maternal-infant dyad and decreases midbrain OPRM1 expression during early postnatal development in rats.

Authors:  Fair M Vassoler; Michelle L Oranges; Anika M Toorie; Elizabeth M Byrnes
Journal:  Pharmacol Biochem Behav       Date:  2018-07-26       Impact factor: 3.533

8.  Limbic oxytocin and arginine 8-vasopressin in morphine tolerance and dependence.

Authors:  G L Kovács; F Laczi; M Vecsernyés; K Hódi; G Telegdy; F A László
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

9.  The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study.

Authors:  Josh D Woolley; Peter A Arcuni; Christopher S Stauffer; Daniel Fulford; Dean S Carson; Steve Batki; Sophia Vinogradov
Journal:  Psychopharmacology (Berl)       Date:  2016-05-03       Impact factor: 4.530

10.  Oxytocin diminishes heroin tolerance in mice.

Authors:  G L Kovács; M Faludi; G Telegdy
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.